The Hibiscus Study™ is inviting adults and adolescents 12 to 65 years old with a clinical diagnosis of sickle cell disease (SCD) to take part in a clinical research study. The primary purpose of the Hibiscus Study is to evaluate the safety and effectiveness of an oral investigational medication to improve anemia and decrease annual pain crises in people with SCD. To learn more about study participation, and to see if you or your adolescent child may qualify, sign up at sicklecellstudy.com

Must live in Miami, Florida area.